PASQUALONE FRANK 4

What Happened

Frank Pasqualone, a director of Enveric Biosciences, was granted 18,518 restricted shares on 2026-06-01. The shares are reported at an acquisition price of $0.00 (transaction code A — award/grant), so the Form 4 records $0 as the purchase price/value for the grant. This is a compensation award, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-01; filing date: 2026-06-03 (no indication in the filing that it was late).
• Shares granted: 18,518; reported price: $0.00; reported total value: $0.
• Shares owned after transaction: not specified in the provided filing.
• Footnote (F1): These are restricted shares issued under the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan and will vest according to the Plan and the director’s restricted stock award agreement.
• Transaction code: A = Award/Grant.

Context

Restricted stock awards are common compensation for directors and typically vest over time and may be forfeitable until vested; they are not the same as an open-market purchase and do not, by themselves, indicate insider buying or selling intent. Retail investors may watch vesting dates and subsequent Form 4s for any sales or transfers once the restrictions lapse.